PHARMOCANN GLOBAL

The current price of PMCN-M is 104.1 ILA — it has increased by 1.07% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange PHARMOCANN GLOBAL stocks are traded under the ticker PMCN-M.

PMCN-M stock is 6.80% volatile and has beta coefficient of 0.22. Check out the list of the most volatile stocks — is PHARMOCANN GLOBAL there?

Yes, you can track PHARMOCANN GLOBAL financials in yearly and quarterly reports right on TradingView.

PMCN-M stock has risen by 4.10% compared to the previous week, the month change is a 39.41% fall, over the last year PHARMOCANN GLOBAL has showed a 63.60% decrease.

PMCN-M net income for the last quarter is ‪−2.69 M‬ ILS, while the quarter before that showed ‪−7.05 M‬ ILS of net income which accounts for 61.83% change. Track more PHARMOCANN GLOBAL financial stats to get the full picture.

No, PMCN-M doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, PMCN-M shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMOCANN GLOBAL stock right from TradingView charts — choose your broker and connect to your account.

PMCN-M reached its all-time high on May 16, 2006 with the price of 639825.3 ILA, and its all-time low was 51.1 ILA and was reached on Mar 26, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 30, 2024, the company has 14.00 employees. See our rating of the largest employees — is PHARMOCANN GLOBAL on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMOCANN GLOBAL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMOCANN GLOBAL stock shows the sell signal. See more of PHARMOCANN GLOBAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMOCANN GLOBAL EBITDA is ‪−8.94 M‬ ILS, and current EBITDA margin is −62.05%. See more stats in PHARMOCANN GLOBAL financial statements.